Sage Capital Advisors,Llc United Therapeutics Corp Transaction History

Sage Capital Advisors,Llc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	BUY	$113.81 - $129.46 $341 - $388	3 New	3 $0
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $2.74 Million - $3.2 Million	-27,064 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$107.21 - $151.94 $7,397 - $10,483	69 Added 0.26%	27,064 $3.04 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $18,024 - $22,994	152 Added 0.57%	26,995 $3.99 Million
Q3 2017 Jul 31, 2019	SELL	$114.6 - $136.81 $15,814 - $18,879	-138 Reduced 0.51%	26,843 $3.15 Million
Q3 2017 Nov 30, 2017	BUY	$114.6 - $136.81 $3.09 Million - $3.69 Million	26,981	26,981 $3.16 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

Stay updated on Sage Capital Advisors,Llc with notifications on news.